Business


Immunai Raises $60M to Reprogram Immunity

The funding will fuel the growth of Immunai’s proprietary AI-first single-cell drug discovery platform Immunai, a New York and Tel Aviv based biotech company, announced today $60M in funding, increasing the company’s total funding-to-date to…









Zyter Acquires Care Management Technology Leader Casenet

Enhances Case Management, Disease Management, and Utilization Management Capabilities Through Collaboration, Interoperability and Advanced Analytics Zyter confirmed today that it has acquired Casenet® LLC, a provider of population health products, from Centene Corporation.  Zyter, a…